Table 2. . Application of nanoparticles-based antiviral agents for disinfection of coronaviruses with some details regarding function and inhibition efficiency.
| Virus | Host | Antiviral substances | Description of antiviral activity type | Antiviral substances concentration | Inhibition | Ref. |
|---|---|---|---|---|---|---|
| FCoV | Cat | GO-Ag nanocomposite | Antiviral activity against enveloped viruses | 0.1 mg/ml | 24.80% | [41] |
| PEDV | Pig | Composites with silver colloid and titanium dioxide nanoparticles | Inhibited the growth of the viruses | 1000-fold diluted from original | ≥99.90% | [37] |
| PEDV | Pig | Ag2S nanoclusters | Inhibition of viral proliferation (in vitro cells = Vero) | 46 μg/ml | ≥99.9% | [40] |
| TGEV | Pig | Composites with silver colloid and titanium dioxide nanoparticles | Inhibited the growth of the viruses | 1000-fold diluted from original | ≥93% | [37] |
| TGEV | Pig | Ag NPs, Ag NW | Inhibition of cell apoptosis induced by the virus (in vitro cells = ST cells) | 3.125–12.5 μg/ml | 7.05–67.35% | [38] |
| FIPV | Cat | Diphyllin nanoparticles | Inhibition of endosomal acidification responsible for virus uncoating and cytoplasmic entry (in vitro cells = fcwf-4) | 2 μM | ≥99.9% | [39] |
| HCoV-NL63 | Human | Bio polymeric nano/microspheres (HTCC-NS/MS) | Capable of adsorbing coronaviruses | 10 mg/500 μl | 99.92% | [42] |
CoV: Coronavirus; FCoV: Feline coronavirus; GO-Ag: Graphene-silver nanocomposites; HTCC-NS/MS: N-(2-hydroxypropyl)-3-trimethyl chitosan-nano/microsphere; MERS: Middle East respiratory syndrome; NP: Nanoparticle; NW: Nanowire; PEDV: porcine epidemic diarrhea virus; ST: Swine testicle; TGEV: Transmissible gastroenteritis.